Impax Laboratories – IPXL – Positive second quarter results
Impax Laboratories, Inc. (NASDAQ: IPXL) reported second quarter 2012 financial results. Adjusted net income increased $28.4 million to $41.0 million in the second quarter 2012, or $0.60 per diluted share, compared to $12.6 million,...